Target intelligence / Profile preview

Neisseria meningitidis serogroup Y capsular polysaccharide antigen

Molecular classification
Other (capsular polysaccharide antigen)
01

Overview

The Neisseria meningitidis serogroup Y capsular polysaccharide antigen is a carbohydrate (polysaccharide) structure forming the outer capsule of Neisseria meningitidis strains classified as serogroup Y. This capsule is the basis of antigenic typing by serogroup, is essential for bacterial survival in the bloodstream, and serves as a key virulence factor by protecting the organism from host immune defenses. The antigen is used in meningococcal conjugate vaccines (such as MenACWY), which induce protective antibody responses and prevent invasive meningococcal disease caused by serogroup Y strains[10][2][5]. The antigen does not function as a receptor, enzyme, or transporter, but rather as a structural and immunogenic component critical for infection, prevention, and serological classification. If you need a mapping or more detail on the specific carbohydrate structure, it consists of a homopolymer of N-acetyl-D-glucosamine-α(2→6)-N-acetyl-D-glucosamine; this "poly-GlcNAc" coil is what constitutes the immunologically reactive serogroup Y capsular polysaccharide[10].

Other names
Meningococcal serogroup Y capsuleSerogroup Y CPS (capsular polysaccharide)Group Y polysaccharide antigen
02

Mechanism of action

Induce production of protective antibodies against serogroup Y antigen by presenting the polysaccharide conjugated to a protein carrier, thereby triggering a T-cell dependent immune response (for conjugate vaccines)

03

Biological functions

Immune evasionVirulence factor
04

Disease associations

Infection
05

Safety considerations

Safety concerns largely pertain to use of polysaccharide vaccines in infants and young children, who do not mount effective immune responses to unconjugated polysaccharides; conjugate vaccines overcome this limitation
06

Interacting drugs

Meningococcal conjugate vaccines (e.g., MenACWY)
07

Biomarkers

Presence of anti-serogroup Y polysaccharide antibodies

Beyond the preview

Go deeper on Neisseria meningitidis serogroup Y capsular polysaccharide antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup Y capsular polysaccharide antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call